John Demaree
2018
In 2018, John Demaree earned a total compensation of $7.5M as Chief Commercial Officer at G1 Therapeutics.
Compensation breakdown
| Bonus | $131,250 |
|---|---|
| Option Awards | $7,107,060 |
| Salary | $185,938 |
| Other | $42,161 |
| Total | $7,466,409 |
Demaree received $7.1M in option awards, accounting for 95% of the total pay in 2018.
Demaree also received $131.3K in bonus, $185.9K in salary and $42.2K in other compensation.
Rankings
In 2018, John Demaree's compensation ranked 1,121st out of 14,244 executives tracked by ExecPay. In other words, Demaree earned more than 92.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,121 out of 14,244 | 92nd |
Division Manufacturing | 380 out of 5,765 | 93rd |
Major group Chemicals And Allied Products | 118 out of 2,128 | 95th |
Industry group Drugs | 91 out of 1,817 | 95th |
Industry Pharmaceutical Preparations | 65 out of 1,391 | 95th |
Source: SEC filing on April 30, 2019.
Demaree's colleagues
We found five more compensation records of executives who worked with John Demaree at G1 Therapeutics in 2018.